Katagiri Seiji, Takahashi Yoshiyuki
Laboratory of Theriogenology, Department of Veterinary Clinical Sciences, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
J Reprod Dev. 2008 Dec;54(6):473-9. doi: 10.1262/jrd.20078. Epub 2008 Oct 15.
The objective of the present study was to examine the efficacy of a progestin-based treatment with a high dose of estradiol benzoate (EB) to normalize the epidermal growth factor (EGF) profile in the uterine endometrium and restore fertility in repeat breeder cows. Repeat breeder cows without peaks in their endometrial EGF concentrations on Days 3 and 14 of the estrous cycle were used throughout the study. The effect of 1 (standard dose), 2.5 and 5 mg of EB in a progestin-based treatment protocol (EB1, EB2.5 and EB5 treatments, respectively; n=5 for each group) on endometrial EGF concentrations was first examined. The EB1 and EB2.5 treatments in the repeat breeder cows produced a suppressed response in endometrial EGF compared with EB1 treatment in the fertile controls (n=5) and failed to restore the normal EGF profile during the next estrous cycle. However, EB5 treatment produced an increase in EGF concentrations similar to the fertile controls and normalized the endometrial EGF profile. The effects of the EB1 and EB5 treatments (n=30 for each group) on the endometrial EGF profile and fertility were then examined in the repeat breeder cows. The proportion of cows, with an EGF profile normalized by the treatments was higher in the EB5 group (66.7%) than in the EB1 (30.0%) and untreated control (13.3%; n=30) groups (P<0.01). The pregnancy rates of the cows having a normal EGF profile after treatment in the EB1 and EB5 groups were similar (88.9 and 85.0%, respectively) and higher than those of the cows having an abnormal profile within the same groups (19.0 and 30.0%, respectively, P<0.01). In summary, the endometrial response to EB in terms of the EGF concentration was suppressed in repeat breeder cows. A high dose (5 mg) of EB in a progestin-based treatment was found to be effective for restoration of a normal EGF profile and fertility in repeat breeder cows having lesser endometrial EGF concentrations on Days 3 and 14.
本研究的目的是检验基于孕激素并联合高剂量苯甲酸雌二醇(EB)的治疗方法对使子宫子宫内膜表皮生长因子(EGF)水平正常化以及恢复屡配不孕奶牛生育能力的疗效。在整个研究过程中,使用发情周期第3天和第14天子宫内膜EGF浓度无峰值的屡配不孕奶牛。首先检验了在基于孕激素的治疗方案中,1mg(标准剂量)、2.5mg和5mg的EB(分别为EB1、EB2.5和EB5治疗组;每组n = 5)对子宫内膜EGF浓度的影响。与可育对照组(n = 5)的EB1治疗相比,屡配不孕奶牛中的EB1和EB2.5治疗使子宫内膜EGF产生了抑制反应,并且在接下来的发情周期中未能恢复正常的EGF水平。然而,EB5治疗使EGF浓度升高,类似于可育对照组,并使子宫内膜EGF水平正常化。然后在屡配不孕奶牛中检验了EB1和EB(每组n = 30)对子宫内膜EGF水平和生育能力的影响。经治疗后EGF水平正常化的奶牛比例,EB5组(66.7%)高于EB1组(30.0%)和未治疗对照组(13.3%;n = 30)(P<0.01)。EB1组和EB5组中治疗后EGF水平正常的奶牛妊娠率相似(分别为88.9%和85.0%),且高于同一组中EGF水平异常的奶牛(分别为19.0%和30.0%,P<0.01)。总之,屡配不孕奶牛子宫内膜对EB的EGF浓度反应受到抑制。发现在基于孕激素的治疗中,高剂量(5mg)的EB对于恢复第3天和第14天子宫内膜EGF浓度较低的屡配不孕奶牛的正常EGF水平和生育能力有效。